Rahman, 50 patient favipiravir late treatment RCT: 89% better improvement [p=0.005] and 92% improved viral clearance [p=0.0008] https://c19p.org/rahman2
copied to clipboard
Safety and Efficacy of Favipiravir for the management of COVID-19 Patients: A Randomized Control Trial
et al., Clinical Infection in Practice, doi:10.1016/j.clinpr.2022.100145
RCT hospitalized patients in Bangladesh, showing faster recovery and viral clearance with favipiravir treatment.
|
risk of no chest x-ray improvement, 89.5% lower, RR 0.11, p = 0.005, treatment 1 of 19 (5.3%), control 8 of 16 (50.0%), NNT 2.2, day 10.
|
|
risk of no chest x-ray improvement, 64.9% lower, RR 0.35, p = 0.007, treatment 5 of 19 (26.3%), control 12 of 16 (75.0%), NNT 2.1, day 7.
|
|
risk of no chest x-ray improvement, 47.4% lower, RR 0.53, p = 0.001, treatment 10 of 19 (52.6%), control 16 of 16 (100.0%), NNT 2.1, day 4.
|
|
risk of no viral clearance, 91.7% lower, RR 0.08, p < 0.001, treatment 1 of 25 (4.0%), control 12 of 25 (48.0%), NNT 2.3, day 10.
|
|
risk of no viral clearance, 62.5% lower, RR 0.38, p = 0.010, treatment 6 of 25 (24.0%), control 16 of 25 (64.0%), NNT 2.5, day 7.
|
|
risk of no viral clearance, 48.0% lower, RR 0.52, p < 0.001, treatment 13 of 25 (52.0%), control 25 of 25 (100.0%), NNT 2.1, day 4.
|
| Effect extraction follows pre-specified rules prioritizing more serious outcomes. Submit updates |
Rahman et al., 5/13/2022, Double Blind Randomized Controlled Trial, placebo-controlled, Bangladesh, South Asia, peer-reviewed, mean age 37.8, 10 authors, study period May 2020 - July 2020, trial NCT04402203.
Contact:
smarahman@du.ac.bd.
Late treatment
is less effective
is less effective
Please send us corrections, updates, or comments. Vaccines and
treatments are both valuable and complementary. All practical, effective, and
safe means should be used. No treatment, vaccine, or intervention is 100%
available and effective for all current and future variants. Denying the
efficacy of any method increases mortality, morbidity, collateral damage, and
the risk of endemic status. We do not provide medical advice. Before taking
any medication, consult a qualified physician who can provide personalized
advice and details of risks and benefits based on your medical history and
situation. FLCCC and WCH
provide treatment protocols.